Nagase H - Search Results

1

Relationship Between Asthma Control Status and Health-Related Quality of Life in Japan: A Cross-Sectional Mixed-Methods Study.

Nagase H, Ito R, Ishii M, Shibata H, Suo S, Mukai I, Zhang S, Rothnie KJ, Trennery C, Yuanita L, Ishii T. Nagase H, et al. Adv Ther. 2023 Nov;40(11):4857-4876. doi: 10.1007/s12325-023-02660-5. Epub 2023 Sep 12. Adv Ther. 2023. PMID: 37698717 Free PMC article.

2

Correction to: Relationship Between Asthma Control Status and Health-Related Quality of Life in Japan: A Cross-Sectional Mixed-Methods Study.

Nagase H, Ito R, Ishii M, Shibata H, Suo S, Mukai I, Zhang S, Rothnie KJ, Trennery C, Yuanita L, Ishii T. Nagase H, et al. Adv Ther. 2024 Feb;41(2):878-880. doi: 10.1007/s12325-023-02723-7. Adv Ther. 2024. PMID: 38038883 Free PMC article. No abstract available.

3

Correction to: Relationship Between Asthma Control Status and Health-Related Quality of Life in Japan: A Cross-Sectional Mixed-Methods Study.

Nagase H, Ito R, Ishii M, Shibata H, Suo S, Mukai I, Zhang S, Rothnie KJ, Trennery C, Yuanita L, Ishii T. Nagase H, et al. Adv Ther. 2024 Dec;41(12):4683-4684. doi: 10.1007/s12325-024-03011-8. Epub 2024 Oct 25. Adv Ther. 2024. PMID: 39453593 Free PMC article. No abstract available.

4

Severe asthma in Japan.

Nagase H. Nagase H. Allergol Int. 2019 Apr;68(2):167-171. doi: 10.1016/j.alit.2019.02.004. Epub 2019 Mar 13. Allergol Int. 2019. PMID: 30878568 Free article. Review.

5

Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan.

Nagase H, Adachi M, Matsunaga K, Yoshida A, Okoba T, Hayashi N, Emoto K, Tohda Y. Nagase H, et al. Allergol Int. 2020 Jan;69(1):53-60. doi: 10.1016/j.alit.2019.06.003. Epub 2019 Jul 13. Allergol Int. 2020. PMID: 31311707 Free article.

6

Effectiveness of mepolizumab in severe asthma in Japan: A real-world study using claims data.

Nagase H, Tamaoki J, Suzuki T, Nezu Y, Katsumata M, Komatsubara M, Mu G, Yang S, Cole AL, Alfonso-Cristancho R. Nagase H, et al. Clin Transl Allergy. 2021 Oct;11(8):e12063. doi: 10.1002/clt2.12063. Clin Transl Allergy. 2021. PMID: 34708944 Free PMC article. No abstract available.

7

Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan.

Nagase H, Tamaoki J, Suzuki T, Nezu Y, Akiyama S, Cole AL, Yang S, Mu G, Katsumata M, Komatsubara M, Alfonso-Cristancho R. Nagase H, et al. Pulm Pharmacol Ther. 2022 Aug;75:102130. doi: 10.1016/j.pupt.2022.102130. Epub 2022 Jun 14. Pulm Pharmacol Ther. 2022. PMID: 35714883 Free article.

8

Changes in disease burden and treatment reality in patients with severe asthma.

Nagase H, Oka H, Uchimura H, Arita Y, Hirai T, Makita N, Tashiro N, Matsunaga K. Nagase H, et al. Respir Investig. 2024 May;62(3):431-437. doi: 10.1016/j.resinv.2024.02.007. Epub 2024 Mar 15. Respir Investig. 2024. PMID: 38492333 Free article.

9

[Current status and perspective of molecular-targeted therapy in asthma].

Nagase H. Nagase H. Arerugi. 2015 Feb;64(1):14-22. Arerugi. 2015. PMID: 25779058 Japanese. No abstract available.

10

[PREVALENCE OF FUNCTIONAL DYSPEPSIA SYMPTOMS IN PATIENTS WITH ASTHMA].

Tomyo F, Sugimoto N, Toyota H, Ito A, Ujino M, Sakasegawa H, Kobayashi K, Koizumi Y, Miyoshi S, Kuramochi M, Yamaguchi M, Yamamoto T, Nagase H. Tomyo F, et al. Among authors: nagase h. Arerugi. 2019;68(9):1132-1140. doi: 10.15036/arerugi.68.1132. Arerugi. 2019. PMID: 31723110 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,560 results

Search Page

Filters